540222:BOM
Laurus Labs Ltd
2.051,10 ₹
arrow_downward
-0,96%(-19,90) 1D
13. okt., 15.51.52 GMT+5.30 · INR
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for 540222...
Ã…bn
2.033,00 ₹
Høj
2.064,00 ₹
Lav
2.008,70 ₹
Markedsværdi
1,11Â bio.
Gns. vol.
88,01Â t
Volumen
67,30Â t
Udbytte
0,10Â %
Kvartalsvis udbytte
0,50 ₹
Ex-dato
8. maj 2026
P/E-forhold
101,41
Højeste i 52 uger
2.071,00 ₹
Laveste i 52 uger
865,00 ₹
Indtægt pr. aktie
20,23 ₹
Aktier i omløb
106,44Â mio.
Antal ansatte
7Â t
Ã…bn
2.033,00 ₹
Høj
2.064,00 ₹
Lav
2.008,70 ₹
Markedsværdi
1,11Â bio.
Gns. vol.
88,01Â t
Volumen
67,30Â t
Udbytte
0,10Â %
Kvartalsvis udbytte
0,50 ₹
Ex-dato
8. maj 2026
P/E-forhold
101,41
Højeste i 52 uger
2.071,00 ₹
Laveste i 52 uger
865,00 ₹
Indtægt pr. aktie
20,23 ₹
Aktier i omløb
106,44Â mio.
Antal ansatte
7Â t
Nyhedshistorier
Fra webkilder og nyhedspartnere
TipRanks
·
for 14 timer siden
Laurus Labs schedules Q2 and H1 FY27 earnings call for October 29
Profil
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Om Laurus Labs Ltd
Administrerende direktørSatyanarayana Chava
Ansatte7,06Â t
Grundlagt2005
Hovedsæde-
Sektor-
Websitelauruslabs.com